Terms: = Skin cancer AND NT5C2, ENSG00000076685, 22978, P49902, PNT5, NT5B, GMP, cN-II AND Prognosis
4 results:
1. Inhibition of tumor intrinsic BANF1 activates antitumor immune responses via cGAS-STING and enhances the efficacy of PD-1 blockade.
Wang M; Huang Y; Chen M; Wang W; Wu F; Zhong T; Chen X; Wang F; Li Y; Yu J; Wu M; Chen D
J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37620043
[TBL] [Abstract] [Full Text] [Related]
2. Lower Expression of GBP2 Associated With Less Immune Cell Infiltration and Poor prognosis in skin Cutaneous Melanoma (SKCM).
Zhang S; Chen K; Zhao Z; Zhang X; Xu L; Liu T; Yu S
J Immunother; 2022 Jul-Aug 01; 45(6):274-283. PubMed ID: 35543550
[TBL] [Abstract] [Full Text] [Related]
3. Characterization of phosphodiesterase 2A in human malignant melanoma PMP cells.
Morita H; Murata T; Shimizu K; Okumura K; Inui M; Tagawa T
Oncol Rep; 2013 Apr; 29(4):1275-84. PubMed ID: 23381931
[TBL] [Abstract] [Full Text] [Related]
4. Increased expression of VEGF-receptors (FLT-1, KDR, NRP-1) and thrombospondin-1 is associated with glomeruloid microvascular proliferation, an aggressive angiogenic phenotype, in malignant melanoma.
Straume O; Akslen LA
Angiogenesis; 2003; 6(4):295-301. PubMed ID: 15166498
[TBL] [Abstract] [Full Text] [Related]
